[96a5a0]: / output / allTrials / identified / NCT00939666_identified.json

Download this file

250 lines (250 with data), 10.8 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
{
"info": {
"nct_id": "NCT00939666",
"official_title": "Minimal Invasive Treatment for Patients With Good Response to Chemoradiation With Selection and Follow-up by MRI: a Single Arm Phase-II Feasibility Study in Rectal Cancer",
"inclusion_criteria": "* 18 years or older\n* Patients with primary rectal cancer without distant metastases who underwent CRT and show clinical complete response or very good response: Clinical complete response (ycT0N0) or very good response (ycT1-2N0) after pre-operative chemoradiation will be determined clinically (digital rectal examination, endoscopy), radiologically (contrast-enhanced-MRI) and pathologically (biopsy)\n* Informed consent and capability of giving informed consent\n* Comprehension of the alternative strategies and the concept of unknown risks are clear to the patient (in other words that the patient understands the experimental base of the study).\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Recurrent rectal cancer.\n* Distant metastasis.\n* Unable or unwilling to comply to the intensive follow-up schedule.\n* Contra-indications for MRI. If MRI is not possible because of contra-indications (e.g. pacemaker) we will exclude patients. MRI is crucial for response evaluation and follow-up and can not be omitted in patients that follow the alternative strategies ('wait-and-see policy' or TEM).",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* 18 years or older",
"criterions": [
{
"exact_snippets": "18 years or older",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Informed consent and capability of giving informed consent",
"criterions": [
{
"exact_snippets": "Informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "capability",
"expected_value": true
}
]
},
{
"exact_snippets": "capability of giving informed consent",
"criterion": "capability to give informed consent",
"requirements": [
{
"requirement_type": "capability",
"expected_value": true
}
]
}
]
},
{
"line": "* Comprehension of the alternative strategies and the concept of unknown risks are clear to the patient (in other words that the patient understands the experimental base of the study).",
"criterions": [
{
"exact_snippets": "Comprehension of the alternative strategies and the concept of unknown risks are clear to the patient",
"criterion": "comprehension of alternative strategies and unknown risks",
"requirements": [
{
"requirement_type": "clarity",
"expected_value": true
}
]
},
{
"exact_snippets": "patient understands the experimental base of the study",
"criterion": "understanding of experimental base",
"requirements": [
{
"requirement_type": "understanding",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Recurrent rectal cancer.",
"criterions": [
{
"exact_snippets": "Recurrent rectal cancer.",
"criterion": "rectal cancer",
"requirements": [
{
"requirement_type": "recurrence",
"expected_value": true
}
]
}
]
},
{
"line": "* Distant metastasis.",
"criterions": [
{
"exact_snippets": "Distant metastasis",
"criterion": "distant metastasis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Unable or unwilling to comply to the intensive follow-up schedule.",
"criterions": [
{
"exact_snippets": "Unable or unwilling to comply to the intensive follow-up schedule.",
"criterion": "compliance to follow-up schedule",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
},
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "* Contra-indications for MRI. If MRI is not possible because of contra-indications (e.g. pacemaker) we will exclude patients. MRI is crucial for response evaluation and follow-up and can not be omitted in patients that follow the alternative strategies ('wait-and-see policy' or TEM).",
"criterions": [
{
"exact_snippets": "Contra-indications for MRI",
"criterion": "MRI contra-indications",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "pacemaker",
"criterion": "pacemaker",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"line": "* Patients with primary rectal cancer without distant metastases who underwent CRT and show clinical complete response or very good response: Clinical complete response (ycT0N0) or very good response (ycT1-2N0) after pre-operative chemoradiation will be determined clinically (digital rectal examination, endoscopy), radiologically (contrast-enhanced-MRI) and pathologically (biopsy)",
"criterions": [
{
"exact_snippets": "primary rectal cancer",
"criterion": "primary rectal cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "without distant metastases",
"criterion": "distant metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "underwent CRT",
"criterion": "chemoradiation therapy (CRT)",
"requirements": [
{
"requirement_type": "completion",
"expected_value": true
}
]
},
{
"exact_snippets": "clinical complete response (ycT0N0)",
"criterion": "clinical complete response",
"requirements": [
{
"requirement_type": "status",
"expected_value": "ycT0N0"
}
]
},
{
"exact_snippets": "very good response (ycT1-2N0)",
"criterion": "very good response",
"requirements": [
{
"requirement_type": "status",
"expected_value": "ycT1-2N0"
}
]
}
]
}
],
"failed_exclusion": [],
"failed_miscellaneous": []
}